Brain Tumor FAQs
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

  • Question: Has GLIADEL® Wafer helped recurrent GBM patients live longer?
  • Answer:05/23/2001
    Yes. LIADEL® Wafer has been shown to extend the lives of patients with recurrent GBM.

    According to one study, 56% of the GBM patients receiving GLIADEL® Wafer during surgery to remove their tumors were still alive after 6 months, as opposed to 36% of patients who only had surgery. The same study showed that the median survival (the length of time half of the patients with GBM in the study survived) went from 20 weeks without GLIADEL® Wafer to 28 weeks with GLIADEL® Wafer – an increase of 41%. Your doctor will be able to give you a better assessment based on your individual situation. (This was taken from the gliadel.com website with permission)
DISCLAIMER
This site is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided at this web site is of a general nature and is not intended to take the place of a physician's advice. We encourage individuals to discuss what they find on this site with their healthcare providers. The answer above was provided by a volunteer, based solely on their experiances and thoughts. These volunteers do not get paid and are not responsible for the accuracy of their responses. IF you disagree with a response, let us know and we will look into it.


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites